Kezar Life Sciences transfer agent is Computershare Trust Company, N.A.. Please see below for the transfer agent contact information:
Computershare Trust Company, N.A.
P.O. Box 43078
Providence RI 02940-3078
Phone (US): (877) 373-6374
Phone (non-US): (781) 575-2879
4000 Shoreline Court, Suite 400, South San Francisco, CA 94080
Kezar’s shares of common stock first started trading on The Nasdaq Global Select Market on June 21, 2018.
Kezar's common stock is traded on The Nasdaq Global Select Market under the symbol “KZR”.
Shares can be purchased through any registered broker. Kezar does not have a direct stock purchase plan
Currently, Kezar Life Sciences does not pay dividends or offer a dividend reinvestment program.
49372L 209.
Kezar’s fiscal year-end is December 31st
KPMG LLP.
You can view our recent press releases by visiting the “Press Releases” section of our website.
Please sign up on the "Email Alerts" page to be added to the Kezar distribution list.
Quarterly and annual reports, as well as other SEC filings, can be accessed in the SEC Filings section site or directly from the SEC at www.sec.gov.
Investor relations inquiries may be submitted to IR@kezarbio.com